Sirolimus in Combination with Cyclosporine or Tacrolimus Plus Methotrexate for Prevention of Graft-versus-Host Disease following Hematopoietic Cell Transplantation from Unrelated Donors

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

2014 • 4,765 citations

1994 Consensus Conference on Acute GVHD Grading.

1995 • 4,743 citations

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

2005 • 3,314 citations

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

1986 • 1,453 citations

Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers

2001 • 981 citations

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

2000 • 922 citations

SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION

1999 • 886 citations

Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program

1993 • 873 citations

Sirolimus: its discovery, biological properties, and mechanism of action

2003 • 717 citations

Hematopoietic Cell Transplantation

2015 • 664 citations

Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.

1990 • 613 citations

Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia

1998 • 587 citations

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

2000 • 574 citations

Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

1998 • 545 citations

BONE MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA

1998 • 429 citations

Thomas' Hematopoietic Cell Transplantation

2009 • 423 citations

Thomas' hematopoietic cell transplantation

2005 • 263 citations

Graft-Versus-Host Disease

2006 • 248 citations

SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1

2001 • 186 citations

Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation

2006 • 186 citations

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft‐versus‐host disease

2005 • 183 citations

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

2003 • 153 citations

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

2004 • 152 citations

Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation

2004 • 141 citations

Graft-Versus-Host Disease

2008 • 139 citations

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

2004 • 130 citations

Sirolimus in liver transplantation

2003 • 124 citations

Rapamycin: FK506's fraternal twin or distant cousin?

1991 • 107 citations

Hyperacute GVHD: risk factors, outcomes, and clinical implications

2006 • 100 citations

Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience

2003 • 86 citations

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation

1999 • 77 citations

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes

2004 • 23 citations